Chugai Pharma USA
Bookmark
ShareCopied to clipboardChugai Pharma USA is a company. It is a public company in Chuo, Japan. It was founded in 1925 and its current CEO is Osamu Okuda. It is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Chuo
- country: Japan
- employees: 7,778 people
- revenues: 7.9B $
- company type: public
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1925
- CEO: Osamu Okuda
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Chugai Pharma USA:
Dataset of stocks from Chugai Pharma USA:
Chugai Pharma USA is one of the companies in Japan, companies in Pharmaceuticals, companies in Health Care, companies in Chuo and 3,456,808 companies in our database.
Talking Points
- 中外製薬株式会社｜創造で、想像を超える。
- Clinical Development, Regulatory Affairs in the U.S. | Chugai's strength in R&D and antibody technologies continues on in global efforts for products and services for the benefit of patients. Chugai Pharma USA, Inc. (CPUSA), located in Berkeley Heights, NJ, is a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd.
- Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.